1-Gram | 3I/Atlas | 732mg Favorite* Alkaloids Per Container

3I / Atlas Crystalline Series-An Interstellar Rarity

Alkaloid Profile (SD Pharm)

Total Alkaloid Content: 73.21%

7-Hydroxymitragynine: 71.37%

Mitragynine Pseudoindoxyl: 1.84%

Packaging Information

Packaging: Purple mylar

Lid: Black

Stickers: Silver

Net Weight: 1 gram

Product Description

31 / Atlas is a crystalline powder formulation refined for precision, clarity, and controlled potency. Light, near-translucent in appearance and ultra-clean to the touch, this release is designed to deliver a bright, crystalline onset that builds smoothly and resolves without turbulence.

Driven by a balanced alkaloid composition anchored by a strong but measured concentration of 7-Hydroxymitragynine, 31 / Atlas provides steady lift, focus, and longevity without crossing into overwhelming intensity. A modest inclusion of Mitragynine Pseudoindoxyl adds depth and structure, supporting a calm, composed experience that remains consistent from start to finish.

This powder sits comfortably in the middle-upper range of the Crystalline Series—ideal for users who value refinement, clarity, and dependable performance over raw force. It is equally suited for standalone use or for pairing with other powders to fine-tune an individualized alkaloid profile.

Caution & Responsible Use

31 / Atlas is not intended for beginners. While smoother and more controlled than higher-tier crystalline releases, it still delivers meaningful potency. Start with a very small amount, allow sufficient time to fully assess effects, and avoid stacking or rapid redosing. Responsible, measured use is essential to maintain both safety and consistency.

This product is not available for shipment to the following states: Alabama, Arkansas, Indiana, Rhode Island, Wisconsin, Florida; or the following counties: San Diego (California), Oceanside (California), Alton (Illinois), Jerseyville (Illinois), Edwardsville County (Illinois), Columbus (Mississippi), Union County (Mississippi), Ascension (Louisiana), Franklin (Louisiana), Ohio, and Rapides (Louisiana).

FDA Disclaimer:

The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure, or prevent any disease.

Kratom products have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) for safety, effectiveness, or as a treatment for any medical condition. The information provided on this website is for educational purposes only and should not be construed as medical advice. Kratom is not intended to diagnose, treat, cure, or prevent any disease.